Study ID: CGX-635-CML-203 | 2007-001286-15

Study Title

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Teva Identifier

CGX-635-CML-203 | 2007-001286-15

ClinicalTrials.gov Identifier

NCT00462943

Study Status

Completed

Trial Condition(s)

Chronic Myeloid Leukemia

Interventions

Drug: Omacetaxine mepesuccinate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
cancer icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

03/01/2007 - 09/01/2013

Phase

Phase 2

Study Type

Interventional